A new biotech start-up – Ouro Medicines – launched today with $120 million in funding from a Series A and a plan to develop ...

A major population proteomics study using UK Biobank patient samples backed by 14 pharma companies has launched today with ...

In October, Intellia reported phase 2 results with NTLA-2002 – which is pitching to become the first approved in vivo CRISPR ...

Researchers in the US have shown that an artificial intelligence algorithm trained to analyse video recordings of sleep tests ...

SearchGPT has the potential to fundamentally change how people seek and discover information. For pharma companies, failing ...

Along with keeping these strategies in mind, it is also important to remember that different formats – digital, print, audio, ...

Investor interest in companies with obesity candidates in their pipeline clearly remains high, given that a brand new ...

Bioanalysis is also used to monitor therapeutic responses by evaluating drug levels, biomarkers, and physiological changes ...

Grifols has filed for US approval of a new drug for rare bleeding disorder acquired fibrinogen deficiency (AFD), which ...

The current rate is a 2.7% gain on diagnosis rates seen before the pandemic and is equivalent to an additional 7,000 early ...

Aviceda Therapeutics has got biotech financing in 2025 off to a flying start by raising $207.5 million to take its lead drug ...

In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical ...